Stay up to date with our latest news, financial reports and company updates.
Coegin Pharma is a Swedish biotechnology company developing cutting-edge innovations for hair growth and skin pigmentation. We plan to launch a hair growth product series by the end of 2025, followed by a skin pigmentation product in 2026. We’re listed on NGM Nordic SME and dual-listed on Börse Stuttgart.
On this page, you’ll find press releases, financial reports, calendar, and shareholder information.
Why invest in Coegin Pharma?
-
Strong scientific foundation
Built on research from NTNU and collaborations with leading universities and partners.
-
Cutting-edge pipeline ready for market
Two proprietary peptides progressing rapidly, with Follicopeptide planned for launch late 2025.
-
Premium positioning in high-growth longevity markets
Addressing underserved needs in hair growth and skin pigmentation within the expanding global longevity trend.
-
Commercial focus and strategic partnerships
Driving efficient market entry through flexible collaborations to maximise reach and impact.
IR contact
